Insider trade

Officer sold ~$363K of BSX shares in the open market

Traded Nov 3, 2025 · Filed Nov 4, 2025

~$363K
Reported value · 3,600 sh @ $100.7481: 225K
Holds after · shares reported: -56.1%
stock since the trade · S&P 500 +11.8%, $98.59 → $43.23 on Oct 1

Why it stands out

Boston Scientific's & Group Pres, Cardiology sold $363K of Boston Scientific shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 3, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 4, 2025

Officer$100K–$500KPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$362,693

Shares × reported transaction price

Timing vs results

12 days after results of Oct 22, 2025, 93 days before results of Feb 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $98.59 on Nov 3, 2025, 16% above its 52-week low and 9% below its high, after a 2% rise over the previous 30 trading days

52-week range $84.72 (Nov 4, 2024) to $108.14 (Sep 8, 2025), 59% of the way up, from 250 adjusted closes. 30 trading days earlier: $97.03 on Sep 22, 2025. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+5.3%	+0.9%	+4.4%
30 days	-1.4%	+1.2%	-2.6%
90 days	-7.4%	+1.8%	-9.1%
180 days	-42.5%	+6.0%	-48.5%

Past results only. Not a forecast.

Source receipt

Record ID: 0001225208-25-008911
Filed / recorded: Nov 4, 2025, 9:15 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: BOSTON SCIENTIFIC CORP
Issuer CIK: 885725
Ticker: BSX
Reporting person: Joseph Michael Fitzgerald
Relationship: Officer
Officer title: EVP & Group Pres, Cardiology
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Nov 3, 2025
Transaction code: S
Shares / units: 3,600
Price per share: $100.7481
Acquired / disposed: Disposed (D)
Shares owned after: 224,742
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 27, 2025.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.72 to $100.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Around the same time

10mo ago

6,952Shares · @ $27.09

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

10mo ago

6,175Shares · @ $24.55

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

10mo ago

3,177Shares · @ $22.71

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record